Pfizer shifts full portfolio to non-profit model in 45 lower-income countries
Pfizer is doubling down on its efforts to address health inequities, shifting its full portfolio to a not-for-profit model in 45 lower-income countries.
The move builds on Pfizer’s “An Accord for a Healthier World” initiative launched back in May to increase access to the pharma giant’s drugs and vaccines. While the initial pledge only included 23 patented products available in the US and EU, the latest commitment covers all on- and off-patent brands, bringing the total offering to about 500 products.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.